Theraclion SA (TCLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.3200
+0.3198 (159,900.00%)
At close: Aug 26, 2024
Theraclion Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 0.83 | 1.82 | 1.24 | 1.48 | 0.74 | Upgrade
|
| Revenue | 0.83 | 1.82 | 1.24 | 1.48 | 0.74 | Upgrade
|
| Revenue Growth (YoY) | -54.44% | 47.49% | -16.58% | 99.05% | -76.23% | Upgrade
|
| Cost of Revenue | 4.66 | 2.9 | 4.29 | 2.88 | 2.25 | Upgrade
|
| Gross Profit | -3.83 | -1.08 | -3.05 | -1.4 | -1.5 | Upgrade
|
| Selling, General & Admin | 3.36 | 3.15 | 3.1 | 3.14 | 2.3 | Upgrade
|
| Other Operating Expenses | -0.76 | -1.29 | -0.03 | -0.14 | 0.34 | Upgrade
|
| Operating Expenses | 2.99 | 2.07 | 3.26 | 3.14 | 2.79 | Upgrade
|
| Operating Income | -6.82 | -3.15 | -6.31 | -4.53 | -4.29 | Upgrade
|
| Interest Expense | -0.02 | -0.03 | -0.04 | -0.07 | -0.26 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.03 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.03 | 0.03 | -0.08 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.06 | -1.89 | -0.02 | -0.08 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | -6.77 | -5.08 | -6.34 | -4.77 | -4.67 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | -0.03 | 0.02 | 0.1 | 0.05 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0 | - | -0 | - | Upgrade
|
| Other Unusual Items | 0.03 | 0.38 | 0.35 | 0.03 | -0.01 | Upgrade
|
| Pretax Income | -6.74 | -4.72 | -5.97 | -4.64 | -4.63 | Upgrade
|
| Income Tax Expense | -0.98 | -1.05 | -1 | -0.88 | -0.72 | Upgrade
|
| Net Income | -5.76 | -3.68 | -4.96 | -3.76 | -3.91 | Upgrade
|
| Net Income to Common | -5.76 | -3.68 | -4.96 | -3.76 | -3.91 | Upgrade
|
| Shares Outstanding (Basic) | 46 | 46 | 32 | 23 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 46 | 32 | 23 | 16 | Upgrade
|
| Shares Change (YoY) | 1.16% | 42.94% | 40.51% | 40.73% | 6.12% | Upgrade
|
| EPS (Basic) | -0.12 | -0.08 | -0.16 | -0.17 | -0.24 | Upgrade
|
| EPS (Diluted) | -0.12 | -0.08 | -0.16 | -0.17 | -0.24 | Upgrade
|
| Free Cash Flow | -3.01 | -2.6 | -5.59 | -4.03 | -3.45 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.06 | -0.17 | -0.18 | -0.21 | Upgrade
|
| Gross Margin | - | -59.29% | -246.91% | -94.22% | -201.94% | Upgrade
|
| Operating Margin | -821.37% | -173.01% | -510.54% | -306.22% | -576.36% | Upgrade
|
| Profit Margin | -693.45% | -201.68% | -401.83% | -253.92% | -524.90% | Upgrade
|
| Free Cash Flow Margin | -362.92% | -142.52% | -452.38% | -272.26% | -464.36% | Upgrade
|
| EBITDA | -6.5 | -2.95 | -6.13 | -4.4 | -4.15 | Upgrade
|
| EBITDA Margin | - | -161.73% | - | -297.36% | - | Upgrade
|
| D&A For EBITDA | 0.32 | 0.21 | 0.18 | 0.13 | 0.14 | Upgrade
|
| EBIT | -6.82 | -3.15 | -6.31 | -4.53 | -4.29 | Upgrade
|
| EBIT Margin | - | -173.01% | - | - | - | Upgrade
|
| Revenue as Reported | 2.16 | 3.92 | 1.37 | 1.71 | 0.74 | Upgrade
|
Updated Nov 1, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.